Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST

BACKGROUND: The Response Evaluation Criteria in Solid Tumors (RECIST) are the current standard for evaluating disease progression or therapy response in patients with solid tumors. RECIST 1.1 calls for axial, longest-diameter (or perpendicular short axis of lymph nodes) measurements of a maximum of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenerty, Kathleen E., Folio, Les R., Patronas, Nicholas J., Marté, Jennifer L., Gulley, James L., Heery, Christopher R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995658/
https://www.ncbi.nlm.nih.gov/pubmed/27553491
http://dx.doi.org/10.1186/s12885-016-2699-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995658/
https://www.ncbi.nlm.nih.gov/pubmed/27553491
http://dx.doi.org/10.1186/s12885-016-2699-x

Ejemplares similares